|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 811.00 GBX | -0.37% |
|
+0.87% | +20.33% |
| 11-26 | UBS cuts Shell; Berenberg says 'buy' Genus | AN |
| 11-24 | Morgan Stanley raises Bridgepoint, cuts Ashmore | AN |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 11.47 | 10.95 | 5.91 | 3.1 | 6.45 | |||||
Return on Total Capital | 13.29 | 12.89 | 7.08 | 3.81 | 8.01 | |||||
Return On Equity % | 17.42 | 16.7 | 9.56 | 6.46 | 10.07 | |||||
Return on Common Equity | 17.42 | 16.7 | 9.56 | 6.46 | 10.07 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 46.13 | 42.08 | 34.5 | 32.11 | 37.56 | |||||
SG&A Margin | 24.24 | 22.08 | 24.25 | 25.55 | 26.05 | |||||
EBITDA Margin % | 21.62 | 19.13 | 10.08 | 5.38 | 10.26 | |||||
EBITA Margin % | 20.79 | 18.32 | 9.32 | 4.67 | 9.5 | |||||
EBIT Margin % | 20.35 | 17.87 | 8.89 | 4.25 | 8.9 | |||||
Income From Continuing Operations Margin % | 16.54 | 14.34 | 7.23 | 4.23 | 6.62 | |||||
Net Income Margin % | 16.54 | 14.34 | 7.23 | 4.23 | 6.62 | |||||
Net Avail. For Common Margin % | 16.54 | 14.34 | 7.23 | 4.23 | 6.62 | |||||
Normalized Net Income Margin | 12.79 | 11.17 | 5.63 | 2.9 | 6.02 | |||||
Levered Free Cash Flow Margin | 12.27 | 10.37 | 0.22 | -5.27 | 13.74 | |||||
Unlevered Free Cash Flow Margin | 12.32 | 10.43 | 0.3 | -5.16 | 13.84 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.9 | 0.98 | 1.06 | 1.17 | 1.16 | |||||
Fixed Assets Turnover | 35.01 | 36.39 | 19.56 | 14.78 | 16.52 | |||||
Receivables Turnover (Average Receivables) | 5.1 | 5.85 | 5.7 | 5.19 | 4.94 | |||||
Inventory Turnover (Average Inventory) | 4.56 | 4.81 | 4.68 | 3.87 | 4.06 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 5.37 | 5.43 | 4 | 3.71 | 3.75 | |||||
Quick Ratio | 4.39 | 4.58 | 2.83 | 2.49 | 2.85 | |||||
Operating Cash Flow to Current Liabilities | 0.85 | 0.92 | 0.15 | -0.06 | 1.14 | |||||
Days Sales Outstanding (Average Receivables) | 71.79 | 62.36 | 64.08 | 70.27 | 74.09 | |||||
Days Outstanding Inventory (Average Inventory) | 80.18 | 75.86 | 77.94 | 94.2 | 90.19 | |||||
Average Days Payable Outstanding | 18.45 | 41.59 | 32.42 | 33.65 | 44.37 | |||||
Cash Conversion Cycle (Average Days) | 133.52 | 96.62 | 109.6 | 130.82 | 119.92 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 0.75 | 1.03 | 7.07 | 6.39 | 4.9 | |||||
Total Debt / Total Capital | 0.75 | 1.02 | 6.6 | 6.01 | 4.68 | |||||
LT Debt/Equity | 0.44 | 0.75 | 5.64 | 4.96 | 3.45 | |||||
Long-Term Debt / Total Capital | 0.43 | 0.74 | 5.27 | 4.66 | 3.28 | |||||
Total Liabilities / Total Assets | 15.35 | 16.22 | 23.23 | 24.2 | 23.36 | |||||
EBIT / Interest Expense | 256.5 | 185.33 | 76.5 | 25.83 | 54.67 | |||||
EBITDA / Interest Expense | 275.5 | 200.67 | 91 | 38.83 | 69.17 | |||||
(EBITDA - Capex) / Interest Expense | 262.5 | 188.67 | 79.5 | 34.5 | 63.67 | |||||
Total Debt / EBITDA | 0.03 | 0.05 | 0.46 | 0.65 | 0.29 | |||||
Net Debt / EBITDA | -2.56 | -2.71 | -2.15 | -1.92 | -2.02 | |||||
Total Debt / (EBITDA - Capex) | 0.04 | 0.05 | 0.53 | 0.73 | 0.32 | |||||
Net Debt / (EBITDA - Capex) | -2.69 | -2.89 | -2.47 | -2.16 | -2.2 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -3.22 | 23.4 | 10.67 | 5.84 | 1.13 | |||||
Gross Profit, 1 Yr. Growth % | -11.56 | 12.55 | -9.24 | -1.52 | 18.29 | |||||
EBITDA, 1 Yr. Growth % | -26.85 | 9.17 | -41.68 | -43.52 | 51.81 | |||||
EBITA, 1 Yr. Growth % | -28.12 | 8.78 | -43.68 | -47.04 | 56.95 | |||||
EBIT, 1 Yr. Growth % | -28.95 | 8.38 | -44.96 | -49.35 | 57.69 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -28.72 | 6.95 | -44.17 | -38.15 | 58.44 | |||||
Net Income, 1 Yr. Growth % | -28.72 | 6.95 | -44.17 | -38.15 | 58.44 | |||||
Normalized Net Income, 1 Yr. Growth % | -28.83 | 7.75 | -44.24 | -45.48 | 59.91 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -28.85 | 6.8 | -44.17 | -38.18 | 58.19 | |||||
Accounts Receivable, 1 Yr. Growth % | -6.08 | 21.92 | 7.02 | 24.48 | -8.23 | |||||
Inventory, 1 Yr. Growth % | 86.06 | -6.46 | 66.02 | 12.48 | -32.25 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 8.7 | 28 | 166.67 | -7.42 | -11.81 | |||||
Total Assets, 1 Yr. Growth % | 14.55 | 12.63 | -7.29 | 0.67 | 2.61 | |||||
Tangible Book Value, 1 Yr. Growth % | 10.1 | 14.77 | -20.48 | -3.44 | 0.78 | |||||
Common Equity, 1 Yr. Growth % | 11.72 | 11.48 | -15.06 | -0.59 | 3.74 | |||||
Cash From Operations, 1 Yr. Growth % | -43.97 | 22.83 | -81.84 | -144.71 | -1.95K | |||||
Capital Expenditures, 1 Yr. Growth % | 0 | 38.46 | 27.78 | -43.48 | 26.92 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -42.17 | 9.6 | -97.6 | -2.58K | -418.9 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -42.07 | 9.77 | -96.84 | -1.94K | -429.03 | |||||
Dividend Per Share, 1 Yr. Growth % | 3.98 | 1.98 | 2 | 2.02 | 1.98 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.05 | 9.28 | 16.86 | 8.23 | 3.45 | |||||
Gross Profit, 2 Yr. CAGR % | -2.72 | -0.23 | 1.07 | -5.46 | 7.93 | |||||
EBITDA, 2 Yr. CAGR % | -15.76 | -10.63 | -20.21 | -42.61 | 4.37 | |||||
EBITA, 2 Yr. CAGR % | -17.02 | -11.58 | -21.73 | -45.39 | 4.42 | |||||
EBIT, 2 Yr. CAGR % | -17.52 | -12.25 | -22.77 | -47.2 | 3.53 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -17.86 | -12.68 | -22.73 | -41.24 | -1.01 | |||||
Net Income, 2 Yr. CAGR % | -17.86 | -12.68 | -22.73 | -41.24 | -1.01 | |||||
Normalized Net Income, 2 Yr. CAGR % | -17.38 | -12.43 | -22.49 | -44.87 | 7.01 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -18.01 | -12.83 | -22.79 | -41.25 | -1.11 | |||||
Accounts Receivable, 2 Yr. CAGR % | -6.08 | 7.01 | 14.23 | 15.42 | 6.88 | |||||
Inventory, 2 Yr. CAGR % | 16.94 | 31.92 | 24.62 | 36.65 | -12.7 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 66.67 | 17.95 | 84.75 | 57.12 | -9.64 | |||||
Total Assets, 2 Yr. CAGR % | 15.08 | 13.59 | 2.19 | -3.39 | 1.64 | |||||
Tangible Book Value, 2 Yr. CAGR % | 20.01 | 12.41 | -4.47 | -12.37 | -1.35 | |||||
Common Equity, 2 Yr. CAGR % | 17.42 | 11.6 | -2.69 | -8.11 | 1.56 | |||||
Cash From Operations, 2 Yr. CAGR % | -8.69 | -17.04 | -52.77 | -71.51 | 187.38 | |||||
Capital Expenditures, 2 Yr. CAGR % | 31.66 | 17.67 | 33.01 | -15.02 | -15.3 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 7.5 | -22.34 | -83.77 | -22.88 | 708.22 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 7.59 | -22.21 | -81.38 | -23.86 | 605.38 | |||||
Dividend Per Share, 2 Yr. CAGR % | 3.99 | 2.97 | 1.99 | 2.01 | 2 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 14 | 9.43 | 9.74 | 13.07 | 5.81 | |||||
Gross Profit, 3 Yr. CAGR % | 8.48 | 2.12 | -3.33 | 0.2 | 1.87 | |||||
EBITDA, 3 Yr. CAGR % | -1.79 | -8.16 | -22.48 | -28.89 | -14.03 | |||||
EBITA, 3 Yr. CAGR % | -2.84 | -9.18 | -23.92 | -31.29 | -15 | |||||
EBIT, 3 Yr. CAGR % | -3.11 | -9.66 | -24.88 | -32.9 | -16.13 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -2.87 | -10.3 | -24.78 | -28.25 | -18.21 | |||||
Net Income, 3 Yr. CAGR % | -2.87 | -10.3 | -24.78 | -28.25 | -18.21 | |||||
Normalized Net Income, 3 Yr. CAGR % | -2.94 | -9.74 | -24.66 | -31.07 | -13.89 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -2.97 | -10.46 | -24.86 | -28.3 | -18.27 | |||||
Accounts Receivable, 3 Yr. CAGR % | 1.22 | 2.46 | 7.01 | 17.55 | 6.93 | |||||
Inventory, 3 Yr. CAGR % | 42.99 | 8.55 | 42.43 | 20.43 | 8.16 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 55.48 | 52.63 | 54.81 | 46.74 | 29.61 | |||||
Total Assets, 3 Yr. CAGR % | 20.21 | 14.26 | 6.15 | 1.68 | -1.43 | |||||
Tangible Book Value, 3 Yr. CAGR % | 32.47 | 18.24 | 0.16 | -4.13 | -8.19 | |||||
Common Equity, 3 Yr. CAGR % | 24.76 | 15.41 | 1.9 | -1.99 | -4.31 | |||||
Cash From Operations, 3 Yr. CAGR % | 3.91 | 0.8 | -50 | -53.62 | 14.47 | |||||
Capital Expenditures, 3 Yr. CAGR % | 28.06 | 33.89 | 20.95 | 0 | -2.86 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 10.6 | 6.42 | -75.62 | -13.3 | 16.2 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 10.68 | 6.54 | -73.26 | -13.99 | 16.27 | |||||
Dividend Per Share, 3 Yr. CAGR % | 13.76 | 3.31 | 2.65 | 2 | 2 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 33.59 | 24.93 | 15.14 | 8.95 | 7.18 | |||||
Gross Profit, 5 Yr. CAGR % | 30.38 | 18.33 | 5.45 | -0.98 | 1.03 | |||||
EBITDA, 5 Yr. CAGR % | 24.65 | 10.98 | -9.62 | -23.9 | -12.69 | |||||
EBITA, 5 Yr. CAGR % | 23.84 | 10.19 | -10.89 | -25.9 | -13.65 | |||||
EBIT, 5 Yr. CAGR % | 24.33 | 10.1 | -11.51 | -27.12 | -14.6 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 25.62 | 10.16 | -11.36 | -24.26 | -16.04 | |||||
Net Income, 5 Yr. CAGR % | 25.62 | 10.16 | -11.36 | -24.26 | -16.04 | |||||
Normalized Net Income, 5 Yr. CAGR % | 25.22 | 10.14 | -11.29 | -25.89 | -13.31 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 25.51 | 10.01 | -11.45 | -24.35 | -16.14 | |||||
Accounts Receivable, 5 Yr. CAGR % | 27.23 | 16.27 | 6.24 | 7.46 | 6.96 | |||||
Inventory, 5 Yr. CAGR % | 43.42 | 28.03 | 35.34 | 19.02 | 17.1 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 66.31 | 52.52 | 66.58 | 54.41 | 24.81 | |||||
Total Assets, 5 Yr. CAGR % | 28.47 | 23.25 | 12.65 | 6.84 | 4.32 | |||||
Tangible Book Value, 5 Yr. CAGR % | 56.7 | 38.52 | 16.23 | 4.88 | -0.45 | |||||
Common Equity, 5 Yr. CAGR % | 31.02 | 25.91 | 12.96 | 5.36 | 1.76 | |||||
Cash From Operations, 5 Yr. CAGR % | 29.76 | 17.8 | -24.2 | -39.19 | 0.64 | |||||
Capital Expenditures, 5 Yr. CAGR % | 48.37 | 34.33 | 30.02 | 11.63 | 4.88 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 34.83 | 18.17 | -49.18 | -6.44 | -1.1 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 34.58 | 18.16 | -46.28 | -6.86 | -1 | |||||
Dividend Per Share, 5 Yr. CAGR % | 38.47 | 20.67 | 8.9 | 2.79 | 2.39 |
- Stock Market
- Equities
- FEVR Stock
- Financials Fevertree Drinks PLC
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















